1. FDA Issues Warning Letters to 30 Telehealth Firms Over 'Illegal' Compounded GLP-1 Sales
The Food and Drug Administration (FDA) on Tuesday sent 30 telehealth companies warning letters about their 'illegal' sales of compounded GLP-1s, building off increasing pressure to tamp down on the unauthorized distribution of these popular weight-loss and diabetes drugs. The agency stated these companies are illegally...